DXSA:F:F-Xtrackers - Euro Stoxx Select Dividend 30 UCITS ETF (EUR)

ETF | Others |

Last Closing

USD 21.405

Change

0.00 (0.00)%

Market Cap

N/A

Volume

3.06K

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-12-22 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
PRAJ:F Amundi Index Solutions - Amund..

N/A

USD 139.20B
UIM5:F UBS (Lux) Fund Solutions - MSC..

N/A

USD 116.19B
SXR8:F iShares Core S&P 500 UCITS ETF..

N/A

USD 109.51B
ZPDJ:F SPDR® MSCI Japan UCITS ETF

-0.25 (-0.44%)

USD 98.97B
XDNY:F Xtrackers MSCI Japan ESG Scree..

-0.04 (-0.27%)

USD 63.27B
SXRZ:F iShares VII PLC - iShares Nikk..

-0.45 (-0.19%)

USD 52.42B
VUSA:F Vanguard Funds Public Limited ..

N/A

USD 51.63B
VUAA:F Vanguard S&P 500 UCITS Acc

+0.41 (+0.38%)

USD 51.63B
XJSE:F Xtrackers II - Japan Governmen..

-0.06 (-0.85%)

USD 38.52B
0ZC:F Zscaler Inc

+7.40 (+4.31%)

USD 37.92B

ETFs Containing DXSA:F

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 2.96% 36% F 52% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 2.96% 33% F 44% F
Trailing 12 Months  
Capital Gain 2.74% 35% F 50% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 2.74% 31% F 43% F
Trailing 5 Years  
Capital Gain -5.16% 26% F 42% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -5.16% 24% F 27% F
Average Annual (5 Year Horizon)  
Capital Gain 4.95% 52% F 54% F
Dividend Return 4.95% 50% F 48% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 12.68% 54% F 84% B
Risk Adjusted Return 38.99% 48% F 59% D-
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.